Yuxiang An , Yan Zhang , Xin Luo , Yaohan Lan , Meiyu Geng , Wenhu Duan , Zuoquan Xie , Hefeng Zhang
{"title":"Discovery of indole derivatives as STING degraders","authors":"Yuxiang An , Yan Zhang , Xin Luo , Yaohan Lan , Meiyu Geng , Wenhu Duan , Zuoquan Xie , Hefeng Zhang","doi":"10.1016/j.ejmech.2025.117747","DOIUrl":null,"url":null,"abstract":"<div><div>Aberrant activation of the stimulator of interferon genes (STING) pathway is associated with the development of various inflammatory and autoimmune diseases. Targeting STING for degradation represents a novel strategy for the treatment of these diseases. In this study, we designed and synthesized a series of STING-PROTACs based on a nitro-free covalent warhead and different E3 ligase binders. The representative compound <strong>2h</strong> specifically degraded STING protein through the proteasome pathway with a DC<sub>50</sub> value of 3.23 μM and exhibited sustained degradation activity over 72 h. Further biological studies demonstrated that compound <strong>2h</strong> inhibited STING signaling and effectively suppressed immune-inflammatory cytokines both <em>in vitro</em> and <em>in vivo</em>. Moreover, compound <strong>2h</strong> offered better safety compared to its warhead molecule and SP23. Collectively, compound <strong>2h</strong> is a potent nitro-free covalent STING degrader and warrants further investigation.</div></div>","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"294 ","pages":"Article 117747"},"PeriodicalIF":6.0000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523425005124","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Aberrant activation of the stimulator of interferon genes (STING) pathway is associated with the development of various inflammatory and autoimmune diseases. Targeting STING for degradation represents a novel strategy for the treatment of these diseases. In this study, we designed and synthesized a series of STING-PROTACs based on a nitro-free covalent warhead and different E3 ligase binders. The representative compound 2h specifically degraded STING protein through the proteasome pathway with a DC50 value of 3.23 μM and exhibited sustained degradation activity over 72 h. Further biological studies demonstrated that compound 2h inhibited STING signaling and effectively suppressed immune-inflammatory cytokines both in vitro and in vivo. Moreover, compound 2h offered better safety compared to its warhead molecule and SP23. Collectively, compound 2h is a potent nitro-free covalent STING degrader and warrants further investigation.
期刊介绍:
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.